Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

EYEN – Eyenovia Inc

Eyenovia, Inc.
EYEN
$0.0626
Name : Eyenovia, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $6,975,205.00
EPSttm : -0.69
finviz dynamic chart for EYEN
Eyenovia, Inc.
$0.0626
5.15%
$0.0034

Float Short %

4.18

Margin Of Safety %

Put/Call OI Ratio

0.2

EPS Next Q Diff

-0.01

EPS Last/This Y

0.06

EPS This/Next Y

0.18

Price

0.06

Target Price

2

Analyst Recom

3

Performance Q

-88.62

Relative Volume

1.44

Beta

1.33

Ticker: EYEN




20 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2024-12-19EYEN0.08880.100.953971
2024-12-20EYEN0.08690.122.364148
2024-12-23EYEN0.08460.120.003948
2024-12-24EYEN0.08560.120.004108
2024-12-26EYEN0.0920.120.024109
2024-12-27EYEN0.09410.100.004911
2024-12-30EYEN0.11320.100.004987
2024-12-31EYEN0.14750.050.019542
2025-01-02EYEN0.11980.040.0213245
2025-01-03EYEN0.10940.040.1514315
2025-01-06EYEN0.1230.040.0714702
2025-01-07EYEN0.1560.040.6915466
2025-01-08EYEN0.11810.180.0318721
2025-01-09EYEN0.11970.180.0418721
2025-01-10EYEN0.10790.180.0318998
2025-01-13EYEN0.09610.1854.4019150
2025-01-14EYEN0.08450.185.7119210
2025-01-15EYEN0.06510.201.3919489
2025-01-16EYEN0.06610.2011.0519605
2025-01-17EYEN0.06110.204.2019721
DateSymbolLastP/C OIP/C VolTotal OI
20 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2024-12-19EYEN0.0943.8- -0.59
2024-12-20EYEN0.0943.8- -0.59
2024-12-23EYEN0.0843.8- -0.59
2024-12-24EYEN0.0943.8- -0.59
2024-12-26EYEN0.0943.8- -0.59
2024-12-27EYEN0.0943.8- -0.59
2024-12-30EYEN0.1143.8- -0.59
2024-12-31EYEN0.1543.8- -0.59
2025-01-02EYEN0.1243.8- -0.59
2025-01-03EYEN0.1143.8- -0.59
2025-01-06EYEN0.1243.8- -0.59
2025-01-07EYEN0.1643.8- -0.59
2025-01-08EYEN0.1243.8- -0.59
2025-01-09EYEN0.1243.8- -0.59
2025-01-10EYEN0.1143.8- -0.59
2025-01-13EYEN0.1043.8- -0.59
2025-01-14EYEN0.0843.8- -0.59
2025-01-15EYEN0.0743.8- -0.59
2025-01-16EYEN0.0743.8- -0.59
2025-01-17EYEN0.0643.8- -0.59
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2024-12-19EYEN290.4841.525.73
2024-12-20EYEN291.2241.525.73
2024-12-23EYEN366.5044.015.73
2024-12-24EYEN366.5044.015.73
2024-12-26EYEN276.6944.013.57
2024-12-27EYEN290.7744.013.57
2024-12-30EYEN265.7843.713.57
2024-12-31EYEN265.7843.713.57
2025-01-02EYEN136.6843.713.57
2025-01-03EYEN290.8743.713.57
2025-01-06EYEN4.0943.713.57
2025-01-07EYEN4.0943.713.57
2025-01-08EYEN3.7443.713.57
2025-01-09EYEN3.7443.713.57
2025-01-10EYEN3.7443.713.57
2025-01-13EYEN3.7443.714.20
2025-01-14EYEN3.7443.714.20
2025-01-15EYEN3.7443.714.20
2025-01-16EYEN4.8743.714.18
2025-01-17EYEN4.8743.714.18
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS

-0.11

Avg. EPS Est. Current Quarter

-0.09

Avg. EPS Est. Next Quarter

-0.12

Insider Transactions

4.87

Institutional Transactions

43.71

Beta

1.33

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

10

Growth Score

36

Sentiment Score

2

Actual DrawDown %

99.2

Max Drawdown 5-Year %

-99.1

Target Price

2

P/E

Forward P/E

PEG

P/S

232.38

P/B

1.45

P/Free Cash Flow

EPS

-0.73

Average EPS Est. Cur. Y​

-0.59

EPS Next Y. (Est.)

-0.41

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-118845.16

Relative Volume

1.44

Return on Equity vs Sector %

-1036.2

Return on Equity vs Industry %

-1023.6

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.03

EBIT Estimation

Eyenovia, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 57
Eyenovia, Inc., a commercial-stage ophthalmic pharmaceutical technology company, engages in developing a pipeline of microdose array print therapeutics. It focuses on commercializing Mydcombi (tropicamide and phenylephrine HCL ophthalmic spray) for inducing mydriasis for routine diagnostic procedures and in conditions where short term pupil dilation is desired, and clobetasol propionate ophthalmic suspension for the treatment of post-operative pain and inflammation following ocular surgery. The company is also developing the Optejet delivery system for use in combination with its drug-device therapeutic programs and for out-licensing for use in combination with therapeutics for additional indications. It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; a license agreement with Arctic Vision (Hong Kong) Limited to develop and commercialize MicroPine, MicroLine, and Mydcombi in China and South Korea; and Senju Pharmaceutical Co., Ltd. to develop and commercialize MicroPine, MicroLine, and Mydcombi. The company has agreement with Formosa Pharmaceuticals. Inc. for Co-Development of Clobetasol Propionate Ophthalmic Suspension (0.05%) for the Treatment of Acute Dry Eye Disease in the U.S. The company was formerly known as PGP Holdings V, Inc. and changed its name to Eyenovia, Inc. in May 2014. Eyenovia, Inc. was incorporated in 2014 and is based in New York, New York.
stock quote shares EYEN – Eyenovia Inc Stock Price stock today
news today EYEN – Eyenovia Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch EYEN – Eyenovia Inc yahoo finance google finance
stock history EYEN – Eyenovia Inc invest stock market
stock prices EYEN premarket after hours
ticker EYEN fair value insiders trading